Biotech Values

[DewDiligence]

Sanofi finally got around to announcing the Lovenox patent decision:

http://biz.yahoo.com/prnews/080515/nyth130.html

>>
District Court Decision Affirmed in U.S. Lovenox® (enoxaparin sodium) Patent Infringement Case

Thursday May 15, 12:28 pm ET

PARIS, May 15 /PRNewswire-FirstCall/ -- Sanofi-aventis announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the February 8, 2007 decision by the U.S. District Court for the Central District of California in the sanofi-aventis Lovenox® patent infringement suit against Amphastar and Teva.

As a result of the Court of Appeals' ruling, the U.S. Lovenox® patent is deemed to be unenforceable.

Sanofi-aventis is considering all its legal options.

While several generic manufacturers have requested marketing approval from the FDA for their products alleged to be generic versions of Lovenox®, sanofi-aventis has not learned of any FDA approval of these requests.
<<